Comparison of prognosis of FIGO stage IB 1 adenocarcinoma and squamous cell carcinoma who were treated primarily by surgery.
- Author:
Jae Yun LIM
1
;
Myung Seop SONG
;
Jae Sik HONG
;
Seok Ju SEONG
;
Tae Jin KIM
;
Kyung Taek LIM
;
Jae Uk SHIM
;
Chong Taik PARK
;
Ki Heon LEE
Author Information
1. Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Sungkyunkwan University School of Medicine, Korea.
- Publication Type:Original Article
- Keywords:
Cervix cancer;
Prognosis;
Survival rate;
Adenocarcinoma
- MeSH:
Adenocarcinoma*;
Carcinoma, Squamous Cell*;
Cervix Uteri;
Female;
Humans;
Hysterectomy;
Lymph Node Excision;
Lymph Nodes;
Multivariate Analysis;
Neoplasm Metastasis;
Prognosis*;
Retrospective Studies;
Survival Rate;
Uterine Cervical Neoplasms
- From:Korean Journal of Gynecologic Oncology
2006;17(3):213-217
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: The objective of this study was to compare clinical and pathologic variables and prognosis of FIGO stage IB 1 adenocarcinoma and squamous cell carcinoma of uterine cervix who were treated primarily by surgery. METHODS: From May 1982 to October 2000, 2,209 patients with invasive cancer of the uterine cervix were diagnosed and treated at Cheil Hospital. A retrospective review was performed of 533 patients with stage IB1 squamous cell carcinoma (group A) and 84 with adenocarcinoma (group B) of cervix who treated primarily by type 3 hysterectomy and pelvic and paraaortic lymphadenectomy. RESULTS: Age, endometrial extension, lymph node metastasis and postoperative adjuvant therapy were not different between two group. There were more the lymphovascular space invasion in group A (136 patients, 25.5%) than group B (9 patients, 10.7%) (p<0.0046). 5 year survival were 95.0% vs 93.8% for group A and group B (p=0.75). Using univariate analysis, pelvic node metastasis, paraaortic metastasis, postoperative adjuvant therapy were significant for survival. Multivariate analysis of 5 year survival revealed independent prognostic factor as postoperative adjuvant therapy. CONCLUSION: Prognosis of FIGO stage IB1 cervical cancer patients who were treated by primarily by type 3 hysterectomy and pelvic and paraaortic lymphadenectomy between adenocarcinoma and squamous cell carcinoma was found to be same.
